Lloyd J. Old
136Patents
20h-index
150Co-inventors
93Inventor score
Filing activity: Aug 31, 1981 → May 31, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7314721B2 | Small cell lung cancer associated antigens and uses therefor | Human Necessities | 81 | Expired |
| US6403373B1 | Isolated nucleic acid molecules associated with colon, renal, and stomach cancer and methods of using these | Chemistry; Metallurgy | 78 | Expired |
| US6342587B1 | A33 antigen specific immunoglobulin products and uses thereof | Chemistry; Metallurgy | 73 | Expired |
| US4579827A | Monoclonal antibodies to human gastrointestinal cancers and hybridoma method of production of the monoclonal antibodies | Emerging Cross-Sectional Technologies | 65 | Expired |
| US6310185A | Recombinant human anti-Lewis Y antibodies | Chemistry; Metallurgy | 58 | Expired |
| US5712369A | Isolated protein which binds to A33 antibody, and peptides corresponding to portions of the protein | Chemistry; Metallurgy | 48 | Expired |
| US5342757A | Monoclonal antibodies which specifically binds to endosialin, a 165 Kd glycoprotein found on tumor vascular endothelium, and uses thereof | Emerging Cross-Sectional Technologies | 42 | Expired |
| US5160723A | Method of imaging colorectal carcinoma lesion and composition for use therein | Emerging Cross-Sectional Technologies | 42 | Expired |
| US4870163A | Preparation of pure human tumor necrosis factor and hybridomas producing monoclonal antibodies to human tumor necrosis factor | Emerging Cross-Sectional Technologies | 41 | Expired |
| US7589180B2 | Specific binding proteins and uses thereof | Chemistry; Metallurgy | 37 | Expired |
| US4970299A | Monoclonal antibodies selective for prostate cancer | Emerging Cross-Sectional Technologies | 33 | Expired |
| US4507391A | Method for detecting the presence of G.sub.D3 ganglioside | Emerging Cross-Sectional Technologies | 32 | Expired |
| US5646253A | Recombinant human anti-LK26 antibodies | Physics | 31 | Expired |
| US4666845A | Monoclonal antibodies to ovarian, cervical and uterine human cancers and method of diagnosis | Emerging Cross-Sectional Technologies | 29 | Expired |
| US4713352A | Monoclonal antibody panel for early diagnosis and therapy of renal carcinoma | Emerging Cross-Sectional Technologies | 25 | Expired |
| US5851526A | Methods of treating colon cancer utilizing tumor-specific antibodies | Chemistry; Metallurgy | 24 | Expired |
| US5102663A | Vaccine for stimulating or enhancing production of antibodies against 9-O-acetyl GD3 | Emerging Cross-Sectional Technologies | 24 | Expired |
| US4693966A | Human monoclonal antibodies from lymphocytes of patients with malignant melanoma | Emerging Cross-Sectional Technologies | 23 | Expired |
| US5804381A | Isolated nucleic acid molecule encoding an esophageal cancer associated antigen, the antigen itself, and uses thereof | Human Necessities | 23 | Expired |
| US7767792B2 | Antibodies to EGF receptor epitope peptides | Human Necessities | 23 | Active |
| US4650756A | Monoclonal antibodies to cell surface antigens of human renal cancer | Emerging Cross-Sectional Technologies | 20 | Expired |
| US4863854A | Monoclonal antibodies to mucin-like human differentiation antigens | Emerging Cross-Sectional Technologies | 20 | Expired |
| US5874060A | Recombinant human anti-Lewis Y antibodies | Chemistry; Metallurgy | 19 | Expired |
| US5431897A | Method of imaging colorectal carcinoma lesion and composition for use therein | Emerging Cross-Sectional Technologies | 18 | Expired |
| US6252052A | Antibodies which bind to NY-ESO-1 cancer associated proteins, and hybridomas which produce these antibodies | Human Necessities | 18 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.